Cadot, S., Ysebaert, L., Lamy, S., Laurent, C., & Quillet-Mary, A. Co-expression of CD69, CD49d, CD279 and CD20 in chronic lymphocytic leukemia cells is a new biomarker of active disease before or under therapy. Ferrata Storti Foundation.
Chicago Style (17th ed.) CitationCadot, Sarah, Loïc Ysebaert, Sébastien Lamy, Camille Laurent, and Anne Quillet-Mary. Co-expression of CD69, CD49d, CD279 and CD20 in Chronic Lymphocytic Leukemia Cells Is a New Biomarker of Active Disease Before or Under Therapy. Ferrata Storti Foundation.
MLA (9th ed.) CitationCadot, Sarah, et al. Co-expression of CD69, CD49d, CD279 and CD20 in Chronic Lymphocytic Leukemia Cells Is a New Biomarker of Active Disease Before or Under Therapy. Ferrata Storti Foundation.
Warning: These citations may not always be 100% accurate.